Vol. 30 (3) 2023 – 13

The effect of hemodiafiltration vs. high-flux hemodialysis on alpha 1-microglobulin level and dialysate albumin loss using a dialyzer surface area of 2.6 m² The Egyptian Journal of Immunology Volume 30 (3), July, 2023 Pages: 124 – 133. www.Ejimmunology.org...

Vol. 30 (3) 2023 – 12

Comparison between levels of Homocysteine, Interleukin-6 and Interleukin-10 in severe cases of Egyptian COVID-19 patients The Egyptian Journal of Immunology Volume 30 (3), July, 2023 Pages: 110 – 123. www.Ejimmunology.org https://doi.org/10.55133/eji.300312 Wafaa A....

Vol. 30 (3) 2023 – 11

NLRP3 inflammasome (rs10754558) gene polymorphism in patients with atopic dermatitis The Egyptian Journal of Immunology Volume 30 (3), July, 2023 Pages: 102 – 109. www.Ejimmunology.org https://doi.org/10.55133/eji.300311 Aya El Gendy1, Fawzia H. Abo Ali1, Shereen A....

Vol. 30 (3) 2023 – 10

Determination of immunological biomarkers in sarcoidosis and their relation to disease activity The Egyptian Journal of Immunology Volume 30 (3), July, 2023 Pages: 92 – 101. www.Ejimmunology.org https://doi.org/10.55133/eji.300310 Radwa S. Ibrahim1, Asmaa S. Hassan1,...

Vol. 30 (3) 2023 – 09

Value of tumor necrosis factor-alpha and high-sensitive cardiac troponin-I as early predictors of subclinical atherosclerosis and their relation to disease activity in patients with rheumatoid arthritis: A case-control study The Egyptian Journal of Immunology Volume...

Vol. 30 (3) 2023 – 08

Soluble CD163 impact as a prognostic biomarker in chronic lymphocytic leukemia The Egyptian Journal of Immunology Volume 30 (3), July, 2023 Pages: 74 – 81. www.Ejimmunology.org https://doi.org/10.55133/eji.300308 Halla M. Ragab1, Hanaa R. M. Attia2, Nabila A....